EGenesis (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- March 25, 2017
- Vertical
- Life Sciences
- Funding URL
- View Funding Page
- Funding Amount:
- $38,000,000
Company Info
- Founders
- Luhan Yang
- Company Description
- EGenesis is a gene editing and genome engineering company developing human-compatible engineered organs to treat diseases.
- Market
- Human transplantable cells, tissues, and organs
- Location
- Cambridge, MA, USA
- Coinvestors
- Alexandria Real Estate Equities, Alta Partners, ARCH Venture Partners, Berggruen Holdings, Biomatics Capital, Fan Ventures, Heritage Provider Network, Uprising